Financials
- Market Capitalization 135.51 M
- Employee 48
- Founded 2015
- CEO N/A
- Website www.alxoncology.com
- Headquarter Delaware, United States
- FIGI BBG00VR8SDG8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.59
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3717 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -6.67% | -12.50% | +35.76% | 136.33 M USD | ||
| 3719 | ANTX AN2 Therapeutics, Inc. - Common Stock | 3.60 USD | -16.28% | -28.29% | -33.70% | +197.52% | 135.85 M USD | ||
| 3735 | RNA Atrium Therapeutics, Inc. - Common Stock | 7.75 USD | -5.60% | -2.52% | -24.09% | -88.98% | 132.57 M USD | ||
| 3736 | VYGR Voyager Therapeutics, Inc. - Common Stock | 2.15 USD | -5.29% | -11.89% | -32.60% | -53.76% | 132.48 M USD |